These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3815911)

  • 1. Effects of verapamil on left ventricular diastolic function at rest and during isometric exercise in patients with hypertrophic cardiomyopathy.
    Bryhn M; Eskilsson J
    Clin Cardiol; 1987 Jan; 10(1):31-6. PubMed ID: 3815911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.
    Bonow RO; Dilsizian V; Rosing DR; Maron BJ; Bacharach SL; Green MV
    Circulation; 1985 Oct; 72(4):853-64. PubMed ID: 4040821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium-channel blocking agents on left ventricular diastolic function in hypertrophic cardiomyopathy and in coronary artery disease.
    Bonow RO
    Am J Cardiol; 1985 Jan; 55(3):172B-178B. PubMed ID: 3881911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diastolic function in hypertrophic cardiomyopathy: effects of propranolol and verapamil on diastolic stiffness.
    Hess OM; Grimm J; Krayenbuehl HP
    Eur Heart J; 1983 Nov; 4 Suppl F():47-56. PubMed ID: 6686544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.
    Bonow RO; Rosing DR; Bacharach SL; Green MV; Kent KM; Lipson LC; Maron BJ; Leon MB; Epstein SE
    Circulation; 1981 Oct; 64(4):787-96. PubMed ID: 7196813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute response of left ventricular filling dynamics to intravenous verapamil predicts the changes in exercise tolerance after oral verapamil therapy in patients with hypertrophic cardiomyopathy.
    Tendera M; Schneeweiss A; Bartoszewski A; Polonski L; Wodniecki J; Salamon A
    Eur Heart J; 1993 Mar; 14(3):410-5. PubMed ID: 8458363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relaxation and regional myocardial stiffness in obstructive hypertrophic cardiopathy patients: effect of verapamil].
    Bonandi L; Hess OM; Grimm J; Krayenbühl HP
    G Ital Cardiol; 1984 Feb; 14(2):77-84. PubMed ID: 6538857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy?
    Hess OM; Murakami T; Krayenbuehl HP
    Circulation; 1986 Sep; 74(3):530-43. PubMed ID: 2943531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.
    Anderson DM; Raff GL; Ports TA; Brundage BH; Parmley WW; Chatterjee K
    Br Heart J; 1984 May; 51(5):523-9. PubMed ID: 6539120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral verapamil effects on global and regional left ventricular diastolic filling in hypertrophic cardiomyopathy.
    Yamagishi T; Ozaki M; Kusukawa R
    Jpn Circ J; 1990 Nov; 54(11):1365-73. PubMed ID: 2287041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: altered left ventricular loading or improved muscle inactivation?
    Paulus WJ; Lorell BH; Craig WE; Wynne J; Murgo JP; Grossman W
    J Am Coll Cardiol; 1983 Nov; 2(5):879-86. PubMed ID: 6685150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe.
    Bonow RO; Ostrow HG; Rosing DR; Cannon RO; Lipson LC; Maron BJ; Kent KM; Bacharach SL; Green MV
    Circulation; 1983 Nov; 68(5):1062-73. PubMed ID: 6684510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of verapamil on diastolic left ventricular function in myocardial hypertrophy of different origin.
    Hess OM; Murakami T; Krayenbühl HP
    Z Kardiol; 1987; 76 Suppl 3():82-6. PubMed ID: 2963452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of verapamil on the indicators of left-ventricular diastole in hypertrophic cardiomyopathy].
    Dabrowski M; Górecka B; Witkowski A; Jodkowski J; Woroszylska M; Ruzyłło W
    Kardiol Pol; 1986; 29(5-6):345-55. PubMed ID: 3784250
    [No Abstract]   [Full Text] [Related]  

  • 15. Isovolumic relaxation period in hypertrophic cardiomyopathy: assessment by radionuclide angiography.
    Betocchi S; Bonow RO; Bacharach SL; Rosing DR; Maron BJ; Green MV
    J Am Coll Cardiol; 1986 Jan; 7(1):74-81. PubMed ID: 3941220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy in pediatric patients: effect of verapamil on regional and global left ventricular diastolic function.
    Pacileo G; De Cristofaro M; Russo MG; Sarubbi B; Pisacane C; Calabrò R
    Can J Cardiol; 2000 Feb; 16(2):146-52. PubMed ID: 10694584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of verapamil in the treatment of hypertrophic cardiomyopathy.
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cor Vasa; 1986; 28(6):404-12. PubMed ID: 3829686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy.
    Hanrath P; Mathey DG; Kremer P; Sonntag F; Bleifeld W
    Am J Cardiol; 1980 Jun; 45(6):1258-64. PubMed ID: 7189640
    [No Abstract]   [Full Text] [Related]  

  • 19. The acute and chronic effects of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy.
    Bonow RO; Rosing DR; Epstein SE
    Eur Heart J; 1983 Nov; 4 Suppl F():57-65. PubMed ID: 6686545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil.
    Bonow RO; Frederick TM; Bacharach SL; Green MV; Goose PW; Maron BJ; Rosing DR
    Am J Cardiol; 1983 May; 51(8):1386-91. PubMed ID: 6682616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.